NDC 87625-101 - SurviveX Travel Med Kit
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87625-101
- Manufacturer
- Intent Brands LLC
- Effective date
- 2026-05-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SurviveX Travel Med Kit - Intent Brands LLC | Intent Brands LLC | 2026-05-07 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | BETTER LIVING BRANDS LLC. | a3fadcc0-97f5-9f9b-e053-2a95a90aeb54 | 2023-03-15 | Warnings | 310965 WK2XYI10QM |
| Advil Allergy and Congestion Relief | CHLORPHENIRAMINE MALEATE, IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE | Navajo Manufacturing Company Inc. | d40bf078-ee6f-4c64-9c74-e4e770c150bf | 2023-03-15 | Warnings | WK2XYI10QM 04JA59TNSJ |
| Advil Sinus Congestion and Pain Relief | IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE | Navajo Manufacturing Company Inc. | 531abadc-37fd-4953-95bc-a211a2ba6914 | 2023-03-15 | Warnings | WK2XYI10QM 04JA59TNSJ |
| Handy Solutions Anti-Diarrheal | LOPERAMIDE HYDROCHLORIDE | Navajo Manufacturing Company Inc. | 76e32e66-4af5-47a5-83ff-cbba206975d6 | 2023-03-15 | Warnings | ANDA074091 978010 77TI35393C |
| Handy Solutions 24 Hour Allergy | LORATADINE | Navajo Manufacturing Company Inc. | 67263031-9095-48f2-8b34-e589b28a7416 | 2023-03-15 | Warnings | ANDA076134 311372 7AJO3BO7QN |
| Ibuprofen | IBUPROFEN | Cardinal Health (Leader) 70000 | e751cb66-5fa5-4171-b061-da34aa10de6c | 2023-03-10 | Warnings | WK2XYI10QM |
| Ibuprofen minis | IBUPROFEN | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | c3f1b721-2bb0-4297-bfc6-7faaf9ba8419 | 2023-03-09 | Warnings | WK2XYI10QM |
| IBU | IBUPROFEN | Proficient Rx LP | ea6f626d-cda3-46e2-9ac9-4e72204cb726 | 2023-03-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Claritin | LORATADINE | Navajo Manufacturing Company | 60a5dc14-3f74-8414-e053-2991aa0ad34a | 2023-03-01 | Warnings | 311372 7AJO3BO7QN |
| Claritin | LORATADINE | Navajo Manufacturing Company Inc. | 219ab9c4-d0c4-4256-ab64-66d0260886bd | 2023-03-01 | Warnings | 311372 7AJO3BO7QN |
| basic care migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Amazon.com Services LLC | edcc7b4b-1317-4060-b947-8c16effc5742 | 2023-02-27 | Warnings | R16CO5Y76E 362O9ITL9D |
| Loratadine | LORATADINE | Walgreens Company | 8229ca40-31cf-3dbd-078d-364f5674cb21 | 2023-02-27 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Dr. Reddy's Laboratories Inc. | 9357186a-9452-e139-01d8-6b8c6f6a2c6b | 2023-02-24 | Warnings | 7AJO3BO7QN |
| Loperamide Hydrochloride | LOPERAMIDE HYDROCHLORIDE | allphamed Pharbil Arzneimittel GmbH | a8c8d1d2-a8c7-462a-b620-729a9baa93c4 | 2023-02-22 | Boxed warning, Warnings, Adverse reactions | 77TI35393C |
| Anticoagulant Citrate Dextrose A | ANHYDROUS CITRIC ACID, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Citra Labs LLC | 5bcd261e-ebba-4ecb-af22-e5aaeb04499b | 2023-02-14 | Warnings, Adverse reactions | XF417D3PSL |
| Acetaminophen | ACETAMINOPHEN | Solupharm Pharmazeutische Erzeugnisse GmbH | adeebc6c-c82f-40dc-b813-1b02244984ce | 2023-02-13 | Warnings, Adverse reactions | 362O9ITL9D |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Ibuprofen | IBUPROFEN | Rite Aid Corporation | a35f04f8-8c7f-5e23-e053-2995a90a30ff | 2023-02-08 | Warnings | WK2XYI10QM |
| Aspirin Enteric Coated | ASPIRIN 81 MG | Lodaat LLC | 04017bc9-602a-4204-96a9-b7f9713155f6 | 2023-01-31 | Warnings | M013 R16CO5Y76E |
| Butalbital, Acetaminophen and Caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Granules Pharmaceuticals Inc. | 74e27dab-9790-47e4-b4f1-3b9df4bce184 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.